Editorial comment
Retinal microvascular damage and nocturnal hypertension: Therapeutic targets to bear in mind
Repercussão microvascular retineana e hipertensão noturna a alvos terapêuticos a não esquecer
José Braz Nogueira
Centro Cardiovascular da Universidade de Lisboa, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal

Assessing the severity of hypertension entails study of damage to target organs, including the retina. Fundoscopy is an important test for this purpose, providing easy direct observation in vivo of the retinal microvasculature, which anatomically and physiologically bears close similarities to cerebral, coronary and renal microvasculature.1,2 The relationship between alterations in the retinal vasculature, assessed qualitatively by fundoscopy using the Keith-Wagener-Barker or Scheie classification systems, and current or previous high blood pressure (BP) has been amply demonstrated, as has their prognostic value for cardiovascular and renal morbidity and mortality, especially in the case of exudative retinopathy.1,3 However, the predictive value of less severe alterations such as arteriolar narrowing, widening of the light reflex and arteriovenous nicking is more uncertain, given the subjective nature of their assessment.2,4 Recent studies using semi-automated computer-based retinal imaging programs applied to high-definition digital photographs and laser Doppler flowmetry, among other techniques, have provided detailed data, not only qualitative but, importantly, quantitative, on a range of parameters of the retinal vasculature including arteriolar wall-to-lumen ratio, caliber, tortuosity, vasomotricity, and branching patterns and relative diameters of arterioles and venules.2,3,5 These, in a more robust fashion than the subjective assessments of older methods, have established or confirmed significant associations between the early structural and functional alterations of the initial stages of hypertension and coronary artery disease, heart failure, stroke, cognitive dysfunction, microalbuminuria and renal dysfunction, left ventricular hypertrophy, and increased carotid intima-media thickness and arterial stiffness.2,3 Some studies have shown the value of these new techniques for predicting the development or worsening of hypertension,2,3,6 and genetic studies have identified loci and polymorphisms that are associated with both changes in arteriolar caliber and regulation or elevation of BP.7,8

Interestingly, some authors have described an association between increased venule caliber and the incidence of hypertension and risk of stroke, especially lacunar stroke.2,3,6

Ambulatory blood pressure monitoring (ABPM) has shown the significance of certain abnormalities in the 24-hour circadian profile with regard to target organ damage and cerebral, cardiovascular and renal morbidity and mortality, as seen in both studies of hypertensives and population studies.1 Of these abnormalities, non-dipping and nocturnal hypertension are most often independently associated with increased risk of target organ damage and worse prognosis, with various studies having shown more severe cardiac, cerebral, renal and macrovascular repercussions in these patients.9-11 It should be noted that there have been few studies on the relationship between vascular abnormalities in hypertensive retinopathy and circadian patterns on ABPM, in particular nocturnal BP, and some are contradictory.12-15

The study by Duarte et al. published in this issue of the Journal16 does in fact analyze precisely this relationship between 24-hour and nocturnal BP by ABPM and the presence and severity of hypertensive retinopathy, assessed qualitatively by fundoscopy and graded using the Scheie classification, in a group of 46 hypertensives, most of them medicated but only a third controlled.

Despite the limitations pointed out by the authors, mainly related to the small study population, the study clearly showed not only the high prevalence of retinopathy in these hypertensives but also the crucial role of nocturnal BP, especially systolic, in the presence and severity of retinopathy. There were also associations between retinopathy and age and duration of hypertension, as described elsewhere,2,3 particularly when the same classification system was used, and in which most patients were in the sclerotic stage of retinopathy (37 patients in the present study). Regarding the mean daytime and nocturnal BP levels of this patient group, unusually, mean nocturnal values were higher than daytime levels, which raises the question whether they included a large number of inverted dippers (which was not the case), or that some may have suffered from obstructive sleep apnea or other sleep disorders, which the authors do not mention. It would have been interesting to know the nocturnal BP levels of dippers and non-dippers in this group, since nocturnal BP can be high even in dippers,17 which may be why there were no differences in the presence and severity of retinopathy between dippers and non-dippers.

The small sample size is probably the reason that no association was found between the presence of retinopathy and cardiac involvement, as has been described in other studies.3 Similarly, medicated and controlled patients were no different in terms of the presence of retinopathy, although improvements in structural alterations of the retinal vasculature have been reported following BP control,3,18 particularly with drugs that act on the renin-angiotensin-aldosterone system and with calcium channel blockers, which were used in this study. Such improvements have been amply demonstrated, especially in cases of exudative retinopathy (which only one patient presented in the study by Duarte et al.) and when the assessment of retinopathy is quantitative as well as qualitative, using sophisticated and precise computer algorithms, which was not the case in the present study. The apparent lack of improvement seen in this study may thus be because BP control had not been achieved for sufficient time to take effect, or due to the methods used to assess retinopathy, or to the patients age and duration of hypertension, leading to a larger proportion of sclerotic lesions that are less likely to regress. If patient numbers had permitted such an analysis, it would have been interesting to assess whether there were significant differences in retinal findings or in nocturnal BP levels between non-medicated and medicated but not controlled subjects.

Furthermore, the study does not report office BP measurements, and thus cannot clarify whether some patients had masked hypertension and if so, whether retinopathy in this group was similar to that of the other hypertensives, as has been reported for other organ damage,9 or how it related to nocturnal BP.

In conclusion, despite the limitations pointed out above with regard to population size and the methodology for assessing the fundoscopy findings, the present study has the merit of demonstrating the importance of nocturnal BP in alterations in the retinal vasculature, and of calling attention to these alterations, which are frequently underestimated and are potential therapeutic targets. They may also play an important role in early assessment of the severity of hypertension, particularly with regard to cardiovascular and renal risk, as well as in monitoring the efficacy of and adherence to antihypertensive medication; when such lesions are detected but the patient has apparently normal BP levels, they may reflect inadequate control of nocturnal BP.

Further studies are awaited, with larger samples and more detailed assessment of the retinal vascular architecture,19 that could widen our understanding of hypertensive microvascular alterations, both arteriolar and venular, and their relationship with changes in circadian BP profiles, therapeutic efficacy, the possible benefits of chronotherapy, and for example in cases of white-coat hypertension the decision whether to initiate antihypertensive therapy.

Conflicts of interest

The author has no conflicts of interest to declare.

T.Y. Wong,P. Mitchell
Hypertensive retinopathy
N Engl J Med, 351 (2004), pp. 2310-2317 http://dx.doi.org/10.1056/NEJMra032865
C.Y. Cheung,W.T. Tay,P. Mitchell
Quantitative and qualitative retinal microvascular characteristics and blood pressure
J Hypertens, 29 (2011), pp. 1380-1391 http://dx.doi.org/10.1097/HJH.0b013e328347266c
M. Bhargava,M.K. Ikram,T.Y. Wong
How does hypertension affect your eyes?
J Hum Hypertens, 26 (2012), pp. 71-83 http://dx.doi.org/10.1038/jhh.2011.37
C. Cuspidi,S. Meani,M. Salerno
Retinal microvascular changes and target organ damage in untreated essential hypertensives
J Hypertens, 22 (2004), pp. 2095-2102
K.A. Ponto,D.J. Werner,L. Wiedemer
Retinal vessel metrics: normative data and their use in systemic hypertension: results from the Gutenberg Health Study
J Hypertens, 35 (2017), pp. 1635-1645 http://dx.doi.org/10.1097/HJH.0000000000001380
J. Ding,K.L. Wai,K. McGeechan
Retinal vascular caliber and the development of hypertension: a meta-analysis of individual participant data
J Hypertens, 32 (2014), pp. 207-215 http://dx.doi.org/10.1097/HJH.0b013e32836586f4
R.A. Jensen,X. Sim,A.V. Smith
Novel genetic loci associated with retinal microvascular diameter
Circ Cardiovasc Genet, 9 (2016), pp. 45-54 http://dx.doi.org/10.1161/CIRCGENETICS.115.001142
M. Kirin,R. Nagy,T.J. MacGillivray
Determinants of retinal microvascular features and their relationships in two European populations
J Hypertens, 35 (2017), pp. 1646-1659 http://dx.doi.org/10.1097/HJH.0000000000001408
E. OBrien,G. Parati,G. Stergiou
European Society of Hypertension position paper on ambulatory blood pressure monitoring
J Hypertens, 31 (2013), pp. 1731-1768 http://dx.doi.org/10.1097/HJH.0b013e328363e964
R.H. Fagard,L. Thijs,J.A. Staessen
Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension
J Hum Hypertens, 23 (2009), pp. 645-653 http://dx.doi.org/10.1038/jhh.2009.9
ABC-H Investigators,G.C. Roush,R.H. Fagard,G.F. Salles
Prognostic impact from clinic, daytime, and night-time systolic blood pressure in nine cohorts of 13,844 patients with hypertension
J Hypertens, 32 (2014), pp. 2332-2340 http://dx.doi.org/10.1097/HJH.0000000000000355
Y. Nakano,T. Oshima,R. Ozono
Non-dipper phenomenon in essential hypertension is related to blunted nocturnal rise and fall of sympatho-vagal nervous activity and progress in retinopathy
Auton Neurosci, 88 (2001), pp. 181-186 http://dx.doi.org/10.1016/S1566-0702(01)00238-7
A. Triantafyllou,M. Doumas,P. Anyfanti
Divergent retinal vascular abnormalities in normotensive persons and patients with never-treated, masked, white coat hypertension
Am J Hypertens, 26 (2013), pp. 318-325 http://dx.doi.org/10.1093/ajh/hps040
M. Salvetti,C. Agabiti Rosei,A. Paini
Relationship of wall-to-lumen ratio of retinal arterioles with clinic and 24-hour blood pressure
Hypertension, 63 (2014), pp. 1110-1115 http://dx.doi.org/10.1161/HYPERTENSIONAHA.113.03004
C. Cuspidi,I. Michev,S. Meani
Reduced nocturnal fall in blood pressure, assessed by two ambulatory blood pressure monitorings and cardiac alterations in early phases of untreated essential hypertension
J Hum Hypertens, 17 (2003), pp. 245-251 http://dx.doi.org/10.1038/sj.jhh.1001546
T. Duarte,S. Gonçalves,R. Brito
Relação entre o perfil tensional nocturno e a prevalência e gravidade de retinopatia hipertensiva
Rev Port Cardiol, 37 (2018), pp. 169-173
C. Cuspidi,C. Sala,C. Valerio
Nocturnal hypertension and organ damage in dippers and nondippers
Am J Hypertens, 25 (2012), pp. 869-875 http://dx.doi.org/10.1038/ajh.2012.49
D. Rosenbaum,A. Mattina,E. Koch
Effects of age, blood pressure and antihypertensive treatments on retinal arterioles remodeling assessed by adaptive optics
J Hypertens, 34 (2016), pp. 1115-1122 http://dx.doi.org/10.1097/HJH.0000000000000894
G. Grassi,R.E. Schmieder
The renaissance of the retinal microvascular network assessment in hypertension: new challenges
J Hypertens, 29 (2011), pp. 1289-1291 http://dx.doi.org/10.1097/HJH.0b013e3283481a4a

Please cite this article as: Nogueira JB. Repercussão microvascular retineana e hipertensão noturna a alvos terapêuticos a não esquecer. Rev Port Cardiol. 2018;37:175177.

Copyright © 2017. Sociedade Portuguesa de Cardiologia


  • Impact Factor: 1.195(2016)
  • SCImago Journal Rank (SJR):0,24
  • Source Normalized Impact per Paper (SNIP):0,398